arrow_back Back to App

New rules for former health officials: limits on vaccine company roles and patents

New rules aim to prevent conflicts of interest for former high-ranking health agency officials. They restrict their ability to work for vaccine companies and to own patents on medicines and vaccines, intending to boost public trust in health decisions.
Key points
Former top officials from health agencies (NIH, FDA, CDC) will be prohibited from serving on boards of entities involved in vaccine development or research.
Top federal officials will not be allowed to own or profit from patents for vaccines or medical treatments, regardless of when the patent was obtained.
These provisions aim to increase transparency and prevent situations where personal interests could influence public health decisions.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_HR_9708
Sponsor: Rep. Gohmert, Louie [R-TX-1]
Process start date: 2023-01-03